TopicNeuro

autism spectrum disorder

33 ePosters25 Seminars

Latest

SeminarNeuroscience

SWEBAGS conference 2024: The involvement of the striatum in autism spectrum disorder

Emanuela Santini
Karolinska Institute
Dec 5, 2024
SeminarNeuroscience

Freeze or flee ? New insights from rodent models of autism

Sumantra “Shona” Chattarji
Director, CHINTA, TCG Centres for Research and Education in Science & Technology, Kolkata, India & Visiting Professor, Simons Initiative for the Developing Brain, University of Edinburgh, UK
Jun 22, 2023

Individuals afflicted with certain types of autism spectrum disorder often exhibit impaired cognitive function alongside enhanced emotional symptoms and mood lability. However, current understanding of the pathogenesis of autism and intellectual disabilities is based primarily on studies in the hippocampus and cortex, brain areas involved in cognitive function. But, these disorders are also associated with strong emotional symptoms, which are likely to involve changes in the amygdala and other brain areas. In this talk I will highlight these issues by presenting analyses in rat models of ASD/ID lacking Nlgn3 and Frm1 (causing Fragile X Syndrome). In addition to identifying new circuit and cellular alterations underlying divergent patterns of fear expression, these findings also suggest novel therapeutic strategies.

SeminarNeuroscience

Myelin Formation and Oligodendrocyte Biology in Epilepsy

Angelika Mühlebner
Universitair Medisch Centrum Utrecht
Feb 16, 2023

Epilepsy is one of the most common neurological diseases according to the World Health Organization (WHO) affecting around 70 million people worldwide [WHO]. Patients who suffer from epilepsy also suffer from a variety of neuro-psychiatric co-morbidities, which they can experience as crippling as the seizure condition itself. Adequate organization of cerebral white matter is utterly important for cognitive development. The failure of integration of neurologic function with cognition is reflected in neuro-psychiatric disease, such as autism spectrum disorder (ASD). However, in epilepsy we know little about the importance of white matter abnormalities in epilepsy-associated co-morbidities. Epilepsy surgery is an important therapy strategy in patients where conventional anti-epileptic drug treatment fails . On histology of the resected brain samples, malformations of cortical development (MCD) are common among the epilepsy surgery population, especially focal cortical dysplasia (FCD) and tuberous sclerosis complex (TSC). Both pathologies are associated with constitutive activation of the mTOR pathway. Interestingly, some type of FCD is morphological similar to TSC cortical tubers including the abnormalities of the white matter. Hypomyelination with lack of myelin-producing cells, the oligodendrocytes, within the lesional area is a striking phenomenon. Impairment of the complex myelination process can have a major impact on brain function. In the worst case leading to distorted or interrupted neurotransmissions. It is still unclear whether the observed myelin pathology in epilepsy surgical specimens is primarily related to the underlying malformation process or is just a secondary phenomenon of recurrent epileptic seizures creating a toxic micro-environment which hampers myelin formation. Interestingly, mTORC1 has been implicated as key signal for myelination, thus, promoting the maturation of oligodendrocytes . These results, however, remain controversial. Regardless of the underlying pathophysiologic mechanism, alterations of myelin dynamics, depending on their severity, are known to be linked to various kinds of developmental disorders or neuropsychiatric manifestations.

SeminarNeuroscience

Myelin Formation and Oligodendrocyte Biology in Epilepsy

Angelika Mühlebner
Universitair Medisch Centrum Utrecht
Oct 19, 2022

Epilepsy is one of the most common neurological diseases according to the World Health Organization (WHO) affecting around 70 million people worldwide [WHO]. Patients who suffer from epilepsy also suffer from a variety of neuro-psychiatric co-morbidities, which they can experience as crippling as the seizure condition itself. Adequate organization of cerebral white matter is utterly important for cognitive development. The failure of integration of neurologic function with cognition is reflected in neuro-psychiatric disease, such as autism spectrum disorder (ASD). However, in epilepsy we know little about the importance of white matter abnormalities in epilepsy-associated co-morbidities. Epilepsy surgery is an important therapy strategy in patients where conventional anti-epileptic drug treatment fails . On histology of the resected brain samples, malformations of cortical development (MCD) are common among the epilepsy surgery population, especially focal cortical dysplasia (FCD) and tuberous sclerosis complex (TSC). Both pathologies are associated with constitutive activation of the mTOR pathway. Interestingly, some type of FCD is morphological similar to TSC cortical tubers including the abnormalities of the white matter. Hypomyelination with lack of myelin-producing cells, the oligodendrocytes, within the lesional area is a striking phenomenon. Impairment of the complex myelination process can have a major impact on brain function. In the worst case leading to distorted or interrupted neurotransmissions. It is still unclear whether the observed myelin pathology in epilepsy surgical specimens is primarily related to the underlying malformation process or is just a secondary phenomenon of recurrent epileptic seizures creating a toxic micro-environment which hampers myelin formation. Interestingly, mTORC1 has been implicated as key signal for myelination, thus, promoting the maturation of oligodendrocytes . These results, however, remain controversial. Regardless of the underlying pathophysiologic mechanism, alterations of myelin dynamics, depending on their severity, are known to be linked to various kinds of developmental disorders or neuropsychiatric manifestations.

SeminarNeuroscience

Counteracting epigenetic mechanisms in autism spectrum disorders

Sofia Lizarraga
University of South Carolina
Oct 12, 2022
SeminarNeuroscience

Neural Circuit Dysfunction along the Gut/Brain Axis in zebrafish models of Autism Spectrum Disorder

Julia Dallman
University of Miami
May 11, 2022
SeminarNeuroscience

Studying cortical development through the lens of autism spectrum disorders

Gaia Novarino
Institute of Science and Technology Austria
Feb 23, 2022
SeminarNeuroscience

Keeping your Brain in Balance: the Ups and Downs of Homeostatic Plasticity (virtual)

Gina Turrigiano, PhD
Professor, Department of Biology, Brandeis University, USA
Feb 17, 2022

Our brains must generate and maintain stable activity patterns over decades of life, despite the dramatic changes in circuit connectivity and function induced by learning and experience-dependent plasticity. How do our brains acheive this balance between opposing need for plasticity and stability? Over the past two decades, we and others have uncovered a family of “homeostatic” negative feedback mechanisms that are theorized to stabilize overall brain activity while allowing specific connections to be reconfigured by experience. Here I discuss recent work in which we demonstrate that individual neocortical neurons in freely behaving animals indeed have a homeostatic activity set-point, to which they return in the face of perturbations. Intriguingly, this firing rate homeostasis is gated by sleep/wake states in a manner that depends on the direction of homeostatic regulation: upward-firing rate homeostasis occurs selectively during periods of active wake, while downward-firing rate homeostasis occurs selectively during periods of sleep, suggesting that an important function of sleep is to temporally segregate bidirectional plasticity. Finally, we show that firing rate homeostasis is compromised in an animal model of autism spectrum disorder. Together our findings suggest that loss of homeostatic plasticity in some neurological disorders may render central circuits unable to compensate for the normal perturbations induced by development and learning.

SeminarNeuroscience

Reward system function and dysfunction in Autism Spectrum Disorders

Camilla Bellone
University of Geneva
Feb 9, 2022
SeminarNeuroscience

Gut-brain signaling as a driver of behavior and gene expression in a mouse model for autism spectrum disorder

Drew Kiraly
Icahn School of Medicine at Mount Sinai
Nov 10, 2021
SeminarNeuroscience

Gestational exposure to environmental toxins, infections, and stressors are epidemiologically linked to neurodevelopmental disorders

Staci D. Bilbo
Duke University
Sep 13, 2021

Gestational exposure to environmental toxins, infections, and stressors are epidemiologically linked to neurodevelopmental disorders with strong male-bias, such as autism spectrum disorder. We modeled some of these prenatal risk factors in mice, by co-exposing pregnant dams to an environmental pollutant and limited-resource stress, which robustly dysregulated the maternal immune system. Male but not female offspring displayed long-lasting behavioral abnormalities and alterations in the activity of brain networks encoding social interactions, along with disruptions of gut structure and microbiome composition. Cellularly, prenatal stressors impaired microglial synaptic pruning in males during early postnatal development. Precise inhibition of microglial phagocytosis during the same critical period mimicked the impact of prenatal stressors on the male-specific social deficits. Conversely, modifying the gut microbiome rescued the social and cellular deficits, indicating that environmental stressors alter neural circuit formation in males via impairing microglia function during development, perhaps via a gut-brain disruption.

SeminarNeuroscience

Making memories in mice

Sheena Josselyn
The Hospital for Sick Children
Jul 1, 2021

Understanding how the brain uses information is a fundamental goal of neuroscience. Several human disorders (ranging from autism spectrum disorder to PTSD to Alzheimer’s disease) may stem from disrupted information processing. Therefore, this basic knowledge is not only critical for understanding normal brain function, but also vital for the development of new treatment strategies for these disorders. Memory may be defined as the retention over time of internal representations gained through experience, and the capacity to reconstruct these representations at later times. Long-lasting physical brain changes (‘engrams’) are thought to encode these internal representations. The concept of a physical memory trace likely originated in ancient Greece, although it wasn’t until 1904 that Richard Semon first coined the term ‘engram’. Despite its long history, finding a specific engram has been challenging, likely because an engram is encoded at multiple levels (epigenetic, synaptic, cell assembly). My lab is interested in understanding how specific neurons are recruited or allocated to an engram, and how neuronal membership in an engram may change over time or with new experience. Here I will describe both older and new unpublished data in our efforts to understand memories in mice.

SeminarNeuroscienceRecording

miRNA dysregulation in embryo results in autism spectrum disorder

Minoo Rassoulzadegan
Université de Nice, INSERM-CNRS, France; Genome and Stem Cell Center, Erciyes University, Kayseri, Turkey
Jun 17, 2021
SeminarNeuroscience

Investigating the environmental etiology of autism spectrum disorder

Magdalena Janecka
Icahn School of Medicine at Mount Sinai
Jun 9, 2021
SeminarNeuroscience

New Strategies and Approaches to Tackle and Understand Neurological Disorder

Mauro Costa-Mattioli
The Memory & Brain Research Center (MBRC), Baylor College of Medicine, Houston, Texas, USA
Mar 18, 2021

Broadly, the Mauro Costa-Mattioli laboratory (The MCM Lab) encompasses two complementary lines of research. The first one, more traditional but very important, aims at unraveling the molecular mechanisms underlying memory formation (e.g., using state-of-the-art molecular and cell-specific genetic approaches). Learning and memory disorders can strike the brain during development (e.g., Autism Spectrum Disorders and Down Syndrome), as well as during adulthood (e.g., Alzheimer’s disease). We are interested in understanding the specific circuits and molecular pathways that are primarily targeted in these disorders and how they can be restored. To tackle these questions, we use a multidisciplinary, convergent and cross-species approach that combines mouse and fly genetics, molecular biology, electrophysiology, stem cell biology, optogenetics and behavioral techniques. The second line of research, more recent and relatively unexplored, is focused on understanding how gut microbes control CNS driven-behavior and brain function. Our recent discoveries, that microbes in the gut could modulate brain function and behavior in a very powerful way, have added a whole new dimension to the classic view of how complex behaviors are controlled. The unexpected findings have opened new avenues of study for us and are currently driving my lab to answer a host of new and very interesting questions: - What are the gut microbes (and metabolites) that regulate CNS-driven behaviors? Would it be possible to develop an unbiased screening method to identify specific microbes that regulate different behaviors? - If this is the case, can we identify how members of the gut microbiome (and their metabolites) mechanistically influence brain function? - What is the communication channel between the gut microbiota and the brain? Do different gut microbes use different ways to interact with the brain? - Could disruption of the gut microbial ecology cause neurodevelopmental dysfunction? If so, what is the impact of disruption in young and adult animals? - More importantly, could specific restoration of selected bacterial strains (new generation probiotics) represent a novel therapeutic approach for the targeted treatment of neurodevelopmental disorders? - Finally, can we develop microbiota-directed therapeutic foods to repair brain dysfunction in a variety of neurological disorders?

SeminarNeuroscience

Promises and pitfalls in going from the bench to the bedside in autism spectrum disorder

Jeremy Veenstra-Vanderweele
Columbia University
Mar 17, 2021
SeminarNeuroscience

Understanding the cellular and molecular landscape of autism spectrum disorders

Karun Singh
Krembil Research Institute, University Health Network, Toronto, Faculty of Medicine, University of Toronto
Mar 15, 2021

Large genomic studies of individuals with autism spectrum disorders (ASD) have revealed approximately 100-200 high risk genes. However, whether these genes function in similar or different signaling networks in brain cells (neurons) remains poorly studied. We are using proteomic technology to build an ASD-associated signaling network map as a resource for the Autism research community. This resource can be used to study Autism risk genes and understand how pathways are convergent, and how patient mutations change the interaction profile. In this presentation, we will present how we developed a pipeline using neurons to build protein-protein interaction profiles. We detected previously unknown interactions between different ASD risk genes that have never been linked together before, and for some genes, we identified new signaling pathways that have not been previously reported. This resource will be available to the research community and will foster collaborations between ASD researchers to help accelerate therapeutics for ASD and related disorders.

SeminarNeuroscience

Molecular Biology of the Fragile X Syndrome

Joel Richter
University of Massachusetts
Nov 17, 2020

Silencing of FMR1 and loss of its gene product, FMRP, results in fragile X syndrome (FXS). FMRP binds brain mRNAs and inhibits polypeptide elongation. Using ribosome profiling of the hippocampus, we find that ribosome footprint levels in Fmr1-deficient tissue mostly reflect changes in RNA abundance. Profiling over a time course of ribosome runoff in wild-type tissue reveals a wide range of ribosome translocation rates; on many mRNAs, the ribosomes are stalled. Sucrose gradient ultracentrifugation of hippocampal slices after ribosome runoff reveals that FMRP co-sediments with stalled ribosomes, and its loss results in decline of ribosome stalling on specific mRNAs. One such mRNA encodes SETD2, a lysine methyltransferase that catalyzes H3K36me3. Chromatin immunoprecipitation sequencing (ChIP-seq) demonstrates that loss of FMRP alters the deployment of this histone mark. H3K36me3 is associated with alternative pre-RNA processing, which we find occurs in an FMRP-dependent manner on transcripts linked to neural function and autism spectrum disorders.

SeminarNeuroscience

Towards therapeutics for Autism Spectrum Disorder using Syngap1 heterozygous mouse model

James Clement
Neuroscience Unit, Jawaharlal Nehru Centre for Advanced Scientific Research
Sep 30, 2020
SeminarNeuroscience

Autism-Associated Shank3 Is Essential for Homeostatic Compensation in Rodent Visual Cortex

Gina Turrigiano
Brandeis University
Jul 21, 2020

Neocortical networks must generate and maintain stable activity patterns despite perturbations induced by learning and experience- dependent plasticity. There is abundant theoretical and experimental evidence that network stability is achieved through homeostatic plasticity mechanisms that adjust synaptic and neuronal properties to stabilize some measure of average activity, and this process has been extensively studied in primary visual cortex (V1), where chronic visual deprivation induces an initial drop in activity and ensemble average firing rates (FRs), but over time activity is restored to baseline despite continued deprivation. Here I discuss recent work from the lab in which we followed this FR homeostasis in individual V1 neurons in freely behaving animals during a prolonged visual deprivation/eye-reopening paradigm. We find that - when FRs are perturbed by manipulating sensory experience - over time they return precisely to a cell-autonomous set-point. Finally, we find that homeostatic plasticity is perturbed in a mouse model of Autism spectrum disorder, and this results in a breakdown of FRH within V1. These data suggest that loss of homeostatic plasticity is one primary cause of excitation/inhibition imbalances in ASD models. Together these studies illuminate the role of stabilizing plasticity mechanisms in the ability of neocortical circuits to recover robust function following challenges to their excitability.

SeminarNeuroscience

Autism spectrum disorder: from gene discovery to functional insights

Silvia De Rubeis
Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York City
Jun 30, 2020

Autism spectrum disorder (ASD) is a neurodevelopmental disorder affecting up to 1% of the population. Over the past few years, large-scale genomic studies have identified hundreds of genetic loci associated with liability to ASD. It is now time to translate these genetic discoveries into functional studies that can help us understand convergences and divergences across risk genes, and build pre-clinical cell and animal models. In this seminar, I will discuss some of the most recent findings on the genetic risk architecture of ASD. I will then expand on our work on biomarkers discovery and neurodevelopmental analyses in two rare genetic conditions associated with ASD: ADNP and DDX3X syndrome.

ePosterNeuroscience

Machine learning of functional network and molecular mechanisms in autism spectrum disorder subtypes

Amanda Buch, Petra Vertes, Jakob Seidlitz, So Hyun Kim, Logan Grosenick, Conor Liston

COSYNE 2023

ePosterNeuroscience

The anti-reward center in Autism Spectrum Disorders (ASDs)

Manuel Scorrano, Giulia Sagona, Anna Letizia Allegra Mascaro, Giorgia Targa, Marco Cambiaghi, Laura Baroncelli

FENS Forum 2024

ePosterNeuroscience

Brain activation patterns in patients with autism spectrum disorder in pain-related perspective-taking: Relationship with interoceptive accuracy

Jung-Woo Son, Seungwon Cheong, Huiyeong Jeon, Hoyeon Lee, Ahjeong Hur, Yong-Wook Shin

FENS Forum 2024

ePosterNeuroscience

Changes in striatal spiny projection neurons’ properties and circuitry in a mouse model of autism spectrum disorder with cholinergic interneuron dysfunction

Juliette Graniou, Xavier Caubit, Pascal Salin, Lydia Kerkerian-Le Goff, Laurent Fasano, Paolo Gubellini

FENS Forum 2024

ePosterNeuroscience

Characterization of the transcriptional landscape of endogenous retroviruses at the fetal-maternal interface in a mouse model of autism spectrum disorder

Martina Giudice, Antonella Camaioni, Anna Maria Tartaglione, Vita Petrone, Claudia Matteucci, Gemma Calamandrei, Paola Sinibaldi-Vallebona, Laura Ricceri, Emanuela Balestrieri, Chiara Cipriani

FENS Forum 2024

ePosterNeuroscience

Characterizing age-related cognitive-motor interactions in individuals with and without autism spectrum disorder using mobile brain-body imaging (MoBI)

Paige Nicklas, John Foxe, Ed Freedman

FENS Forum 2024

ePosterNeuroscience

Deciphering the neurodevelopmental role of the brain secretome in Autism Spectrum Disorder

Simon Schnabl, Romina Antonela Gisonno, Gaia Novarino

FENS Forum 2024

ePosterNeuroscience

Effect of ENERGI in valproate-induced animal with autism spectrum disorder

Chi-Chun Wu, Ming-Chia Chu, Chi-Wei Lee, Hui-Ching Lin

FENS Forum 2024

ePosterNeuroscience

Electrophysiologic, transcriptomic, and morphologic plasticity of spinal inhibitory neurons to decipher atypical mechanosensory perception in Autism Spectrum Disorder

Anna Saint-Jean, Vanessa Rouglan, Florian Specque, Alexis Groppi, Macha Nikolski, Alexandre Favereaux, Yves Le Feuvre

FENS Forum 2024

ePosterNeuroscience

Exploring altered translation in autism spectrum disorder

Jose Ignacio Astorga, Marija Mihailovic, Matthias Selbach

FENS Forum 2024

ePosterNeuroscience

GPR50-mediated mitophagy in the pathogenesis of autism spectrum disorders

Quan-Hong Ma

FENS Forum 2024

ePosterNeuroscience

Hyposensitivity to thermal stimulus with prefrontal cortical implication in two animal models of autism spectrum disorder

Ming-chia Chu, Pei-Yu Kao, Ssu-Chi Tsai, Han-Fang Wu, Hsiang Chi, Shu-Jui Chia, Yi-Chao Lee, Hui-Ching Lin

FENS Forum 2024

ePosterNeuroscience

The impact of autism spectrum disorder-risk genes on human neural stem cell proliferation and survival

Francesca Barbieri, Gintarė Sendžikaitė, Martina Rispoli, Simon Haendeler, Denise Haslinger, Hagar Moussa, Arndt von Haeseler, Gaia Novarino

FENS Forum 2024

ePosterNeuroscience

Impact of a cocktail of fungicides at the regulatory dose in Europe on the neurodevelopment of a mice model of Autism Spectrum Disorders (ASD)

Lucie Salvador-Prince, Dorine Thobois, Jason Durand, Véronique Perrier, Karine Loulier

FENS Forum 2024

ePosterNeuroscience

Impaired excitatory and inhibitory synaptic plasticity in the NLGN3-R451C mouse model of autism spectrum disorder

Martina Bruno, Stefka Stancheva, Massimo Ruben, Alice Polenghi, Francesco Colaci, Enrica Petrini, Andrea Barberis

FENS Forum 2024

ePosterNeuroscience

Investigating the role of the PTCHD1-PTCHD1-AS risk locus in Autism Spectrum Disorder

Clarrisa Bradley, Sangyoon Ko, Lia D'Abate, Jinyeol Lee, Tianyi Lu, Junhui Wang, Xiaolian Fang, Graham Collingridge, Paul Frankland, Stephen Scherer

FENS Forum 2024

ePosterNeuroscience

Involvement of amygdala neurons in male predominance of Autism Spectrum Disorder

Noa Montefiore, Reut Suliman Lavie, Sagiv Shifman, Yosef Yarom

FENS Forum 2024

ePosterNeuroscience

Mapping the cell state landscape of autism spectrum disorders

Lena Schwarz, Christoph P. Dotter, Christoph Bueschl, Sergey Isaev, Sabrina Ladstaetter, Barbara Oliveira, Bernadette Basilico, Matteo Barel, Satish Arcot Jayaram, Igor Adameyko, Christoph Bock, Gaia Novarino

FENS Forum 2024

ePosterNeuroscience

The mGlu4 positive allosteric modulator foliglurax durably rescues behavioral deficits in three mouse models of autism spectrum disorder

Mathieu Fonteneau, Claire Terrier, Flavie Derouin Tochon, Agathe Brugoux, Delphine Charvin, Julie Le Merrer, Jérôme AJ Becker

FENS Forum 2024

ePosterNeuroscience

mTOR pathway disruption in GABAergic neurons impacts morphological and functional development of cortical and thalamic somatosensory areas in a mouse model of autism spectrum disorder

Marcin Lipiec, Karolina Bogaj, Joanna Urban-Ciećko, Mateusz Grabowski, Jadwiga Zymer, Emilia Kolada-Nowak, Jarosław Barski, Ewelina Knapska

FENS Forum 2024

ePosterNeuroscience

Neuronal activities during a VR-based assessment for Autism Spectrum Disorder: A pilot EEG study

Chun-Chuan Chen, Yu Jung Tseng, Hui-Ju Chen, Tzu-Ling Lin, Yu-Hsin Huang, Shih-Ching Yeh, Eric Hsiao Kuang Wu

FENS Forum 2024

ePosterNeuroscience

Neuronal correlates of increased behavioral inhibition by interoceptive stimulation in a mouse model of autism spectrum disorder

Nino Kobakhidze, Simone B. Sartori, Sarah Gorkiewicz, Francesca Silvagni, Arnau Ramos-Prats, Claudia Claudia Schmuckermair, Pawel M. Matulewicz, Francesco Ferraguti, Gaia Novarino, Nicolas Singewald

FENS Forum 2024

ePosterNeuroscience

Neurophysiology of perceptual closure abilities in children with autism spectrum disorder and neurotypical control children

Erin Bojanek, Edward G. Freedman, John J. Foxe

FENS Forum 2024

ePosterNeuroscience

De novo variants in SP9 cause a novel form of interneuronopathy characterized by intellectual disability, autism spectrum disorder, and epilepsy with variable expressivity

Gaelle Friocourt, Marine Tessarech, Florent Marguet, Maryline Lecointre, Morgane Le Mao, Rodrigo Muñoz Díaz, Cyril Mignot, Boris Keren, Bénédicte Héron, Charlotte De Bie, Koen Van Gassen, Didier Loisel, Benoit Delorme, Steffen Syrbe, Annick Klabunde-Cherwon, Rami Abou Jamra, Meret Wegler, Bert Callewaert, Annelies Dheedene, Merzouka Zidannes-Marinnes, Agnès Guichet, Céline Bris, Patrick Van Bogaert, Florence Biquard, Guy Lenaers, Pascale Marcorelles, Claude Ferec, Bruno Gonzales, Vincent Procaccio, Antonio Vitobello, Dominique Bonneau, Annie Laquerriere, Salim Khiati, Estelle Colin

FENS Forum 2024

ePosterNeuroscience

Olfactory discrimination and reversal learning in the Neurexin1 (+/-) mouse model of autism spectrum disorder

Richard Brown

FENS Forum 2024

ePosterNeuroscience

Oxytocin ameliorates aggression in a mouse model of autism spectrum disorder (ASD)

Zhuoni Li, Alexandra Hertz, Eilidh MacNicol, Davide Di Censo, Eugene Kim, Declan Murphy, Michael Craig, Diana Cash, Marija M. Petrinovic

FENS Forum 2024

ePosterNeuroscience

Prefrontal cortex alterations underlying attentional modulation of sensory information in the Fmr1KO mouse model of autism spectrum disorder

Maria Gueidão Costa, Awen Louboutin, Ourania Semelidou, Roman Böhringer, Ignacio J. Marín Blasco, Andreas Frick, Olga Peñagarikano, Melanie Ginger

FENS Forum 2024

ePosterNeuroscience

Rectifying interneuron developmental trajectory prevents the core symptoms of autism spectrum disorder in mice

Shaam Al Abed, Nathan Reynolds, William Kwan, Rhea Laverock, Archana Sritharan, Yovina Sontani, Alexandre Rcom-H'cheo-Forgues, Mirindra Ratsifandrihamanana, Michel Picardo, Nathalie Dehorter

FENS Forum 2024

ePosterNeuroscience

The selective deletion of an autism spectrum disorder associated gene in a neuronal subpopulation causes subtle anxiety-related abnormalities

Francesca Silvagni, Claudia Schmuckermair, Nino Kobakhidze, Sarah Gorkiewicz, Pawel Matulewicz, Arnau Ramos-Prats, Simone B. Sartori, Gaia Novarino, Nicolas Singewald, Francesco Ferraguti

FENS Forum 2024

ePosterNeuroscience

The social behaviorome in mouse models of autism spectrum disorders (ASD)

Sarah Gorkiewicz, Mary Muhia, Christoph Sommer, Marco Dalla Vecchia, Gaia Novarino

FENS Forum 2024

ePosterNeuroscience

Tactile sensory processing deficits in the Shank3 KO mouse model of autism spectrum disorder

Margarida Falcão, Patrícia Monteiro, Luis Jacinto

FENS Forum 2024

ePosterNeuroscience

Unraveling gender disparities in autism spectrum disorders: The impact of immunological factors in a mouse model of autism

Araceli Seiffe, Nadia Kazlauskas, Marcos Campolongo, Amaicha Mara Depino

FENS Forum 2024

ePosterNeuroscience

Upregulation of Negr1 converges into core impaired processes in autism spectrum disorders

Mariam Marie Chellali, Amos Fumagalli, Olga Shevtsova, Ilias Ziogas, Giulia Colombo, Giovanni Morelli, Andrea Barberis, Francesca Porceddu, Angelo Reggiani, Alessandro Gozzi, Yuri Bozzi, Giovanni Piccoli, Laura Cancedda

FENS Forum 2024

autism spectrum disorder coverage

58 items

ePoster33
Seminar25
Domain spotlight

Explore how autism spectrum disorder research is advancing inside Neuro.

Visit domain